XML 41 R31.htm IDEA: XBRL DOCUMENT v3.22.0.1
Business Segment Information (Tables)
6 Months Ended
Jan. 31, 2022
Segment Reporting [Abstract]  
Schedule of operating results for the business segments
(unaudited, in thousands)  Pharmaceuticals   Real Estate   Total 
Three Months Ended January 31, 2022            
Revenues  $
   $1,110   $1,110 
Loss from operations   (1,621)   (89)   (1,710)
Loss before income taxes   (2,472)   (89)   (2,561)
                
Three Months Ended January 31, 2021               
Revenues  $
   $959   $959 
Loss from operations   (10,301)   (516)   (10,817)
Loss before income taxes   (7,813)   (516)   (8,329)

 

(unaudited, in thousands)  Pharmaceuticals   Real Estate   Total 
Six Months Ended January 31, 2022            
Revenues  $
   $2,136   $2,136 
Loss from operations   (50,966)   (240)   (51,206)
Loss before income taxes   (131,157)   (240)   (131,397)
                
Six Months Ended January 31, 2021               
Revenues  $
   $2,012   $2,012 
Loss from operations   (12,435)   (873)   (13,308)
Loss before income taxes   (9,727)   (124)   (9,851)

 

Schedule of revenues from these non-United States customers as a percentage of total revenues

Three Months Ended January 31, (unaudited)

  2022   2021 
Revenue from tenants located in Israel   7%   7%

 

Six Months Ended January 31, (unaudited)  2022   2021 
Revenue from tenants located in Israel   7%   7%

 

Schedule of net long-lived assets
(unaudited, in thousands)  United States   Israel   Total 
January 31, 2022            
Long-lived assets, net  $41,038   $1,499   $42,537 
Total assets   117,930    4,638    122,568 
                
July 31, 2021               
Long-lived assets, net  $41,704   $1,534   $43,238 
Total assets   150,847    3,208    154,055